跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ANTITHROMBIN III IMMUNO - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ANTITHROMBIN III IMMUNO
Authorized
STANDARD
ANTITHROMBIN III IMMUNO
Baxter AG
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
889786a0d403d34c
Company
Baxter AG
Type
Standard
Approval Details
Approval Id
889786a0d403d34c
Drug Approval Canada Name
ANTITHROMBIN III IMMUNO
Product Name
ANTITHROMBIN III IMMUNO
Status
Cancelled Post Market
Status Date
2011-10-07
Original Market Date
1999-07-05
Din
02237812
Drug Class
Human
Dosage Form
Powder For Solution
Route Of Administration
Intravenous
Schedule
Schedule D
Ahfs
20:12.04.12
Atc Original
B01AB02 ANTITHROMBIN
Atc Name
b 01 ab 02
Aig Number
0224213003
Company Name
Baxter AG
Company Address
Industriestrasse 67, Vienna, Saone Et Loire, Austria, 1220
Company Detail Path
/organization/baxter-ag
Company Information
Pharmaceutical Company Name
Baxter AG
Country Name
Switzerland
Province Name
Zürich
City Name
glattpark (opfikon),zürich,country_ch
Address
Thurgauerstrasse 130
Website
http://www.baxter.ch
Active Ingredients
ANTITHROMBIN III (HUMAN)
1650 UNIT / KIT
WATER
30 ML / KIT
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
889786a0d403d34c
Type
Standard
Back to Health Canada Approvals